JP2003501432A - ペルオキシ亜硝酸塩分解触媒およびその使用方法 - Google Patents

ペルオキシ亜硝酸塩分解触媒およびその使用方法

Info

Publication number
JP2003501432A
JP2003501432A JP2001502426A JP2001502426A JP2003501432A JP 2003501432 A JP2003501432 A JP 2003501432A JP 2001502426 A JP2001502426 A JP 2001502426A JP 2001502426 A JP2001502426 A JP 2001502426A JP 2003501432 A JP2003501432 A JP 2003501432A
Authority
JP
Japan
Prior art keywords
complex
formula
peroxynitrite
substituted
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001502426A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン ティー． グローブス，
スーザン エム． モエラー，
Original Assignee
ザ トラスティーズ オブ プリンストン ユニバーシテイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ トラスティーズ オブ プリンストン ユニバーシテイ filed Critical ザ トラスティーズ オブ プリンストン ユニバーシテイ
Publication of JP2003501432A publication Critical patent/JP2003501432A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/005—Compounds of elements of Group 5 of the Periodic System without metal-carbon linkages
JP2001502426A 1999-06-03 2000-06-02 ペルオキシ亜硝酸塩分解触媒およびその使用方法 Withdrawn JP2003501432A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13730899P 1999-06-03 1999-06-03
US60/137,308 1999-06-03
US09/587,382 US6448239B1 (en) 1999-06-03 2000-06-01 Peroxynitrite decomposition catalysts and methods of use thereof
US09/587,382 2000-06-01
PCT/US2000/015269 WO2000075144A2 (en) 1999-06-03 2000-06-02 Peroxynitrite decomposition catalysts and methods of use thereof

Publications (1)

Publication Number Publication Date
JP2003501432A true JP2003501432A (ja) 2003-01-14

Family

ID=26835128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502426A Withdrawn JP2003501432A (ja) 1999-06-03 2000-06-02 ペルオキシ亜硝酸塩分解触媒およびその使用方法

Country Status (6)

Country Link
US (3) US6448239B1 (US06448239-20020910-C00004.png)
EP (1) EP1185532A1 (US06448239-20020910-C00004.png)
JP (1) JP2003501432A (US06448239-20020910-C00004.png)
AU (1) AU780118B2 (US06448239-20020910-C00004.png)
CA (1) CA2373336A1 (US06448239-20020910-C00004.png)
WO (1) WO2000075144A2 (US06448239-20020910-C00004.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012105483A1 (ja) * 2011-01-31 2012-08-09 国立大学法人宇都宮大学 ポルフィリン型骨格を有する化合物の金属錯体の製造方法
JP2015020986A (ja) * 2013-07-22 2015-02-02 学校法人同志社 抗癌剤、金属錯体及び複素環化合物

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
EP1155019B1 (en) 1999-01-25 2005-12-07 National Jewish Medical and Research Center Substituted porphyrins and their therapeutic use
US20030032634A1 (en) 2001-06-01 2003-02-13 Piganelli Jon D. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
US6448239B1 (en) * 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
US6403788B1 (en) 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
US20020072512A1 (en) * 2000-12-08 2002-06-13 Metaphore Pharmaceuticals, Inc Method of preventing and treating HIV-mediated central nervous system damage
US20040137638A1 (en) * 2002-03-04 2004-07-15 Slomczynska Urszula J. Chromatography of metal complexes
DE10240343A1 (de) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren
US20040127479A1 (en) * 2002-08-27 2004-07-01 Merck Patent Gmbh Peroxynitrite rearrangement catalysts
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
US20050025804A1 (en) * 2003-07-28 2005-02-03 Adam Heller Reduction of adverse inflammation
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US7807825B2 (en) 2004-02-09 2010-10-05 Duke University Substituted porphyrins
US8165651B2 (en) * 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
EP1740094A4 (en) * 2004-03-29 2008-09-03 Inotek Pharmaceuticals Corp PYRIDYL-SUBSTITUTED PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
CA2595236A1 (en) * 2005-01-19 2006-07-27 Pharmacyclics, Inc. A method for treating neurologic diseases
JP2006224318A (ja) * 2005-02-15 2006-08-31 Brother Ind Ltd インクジェット記録装置
WO2007038630A2 (en) 2005-09-28 2007-04-05 Inotek Pharmaceuticals Corporation N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US8334377B2 (en) 2006-10-06 2012-12-18 The Trustees Of Princeton University Porphyrin catalysts and methods of use thereof
US8232267B2 (en) * 2006-10-06 2012-07-31 The Trustees Of Princeton University Porphyrin catalysts and methods of use thereof
EP2056675B1 (en) 2006-10-12 2019-01-09 Galera Labs, LLC Methods of treating oral mucositis
WO2009027965A1 (en) * 2007-08-28 2009-03-05 Technion Research And Development Foundation Ltd. Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
US20100316622A1 (en) * 2007-11-02 2010-12-16 University Of Miami Diagnosis and treatment of cardiac disorders
EP2732817B1 (en) 2008-05-23 2016-08-24 National Jewish Health A compound for use in treating injury associated with exposure to phosgene or chlorine gas
CA2762474A1 (en) * 2009-05-26 2010-12-02 Duke University Method of providing neuroprotection using substituted porphyrins
WO2012033916A1 (en) * 2010-09-08 2012-03-15 Southern Illinois University Edwardsville Method for treating chronic pain
CA2845854A1 (en) 2011-08-19 2013-02-28 The Trustees Of Princeton University C-halogen bond formation
JP6267638B2 (ja) 2011-09-26 2018-01-24 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーＧａｌｅｒａ Ｌａｂｓ， Ｌｌｃ 疾患の治療方法
EP2911662A4 (en) * 2012-10-25 2016-09-28 Technion Res & Dev Foundation METHOD OF TREATING A DISEASE
WO2014126968A1 (en) 2013-02-13 2014-08-21 California Institute Of Technology Sulfonic esters of metal oxides and methods of their use
WO2015054476A1 (en) 2013-10-09 2015-04-16 The Trustees Of Princeton University C-halogen bond formation
WO2015102745A1 (en) 2013-12-31 2015-07-09 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3094356A4 (en) * 2014-01-17 2017-06-14 California Institute of Technology Sulfonic esters of metal oxides and methods of their use
WO2015153863A1 (en) * 2014-04-03 2015-10-08 John Wayne Kennedy Copper/zinc superoxide dismutase (sod) formulation for the treatment of traumas including amyotropic lateral sclerosis
US9364537B2 (en) 2014-08-22 2016-06-14 University Of Dayton Transition metal porphyrin complexes and methods of treatment using same
SG10202002859QA (en) 2015-08-11 2020-05-28 Galera Labs Llc Pentaaza macrocyclic ring complexes possessing oral bioavailability
CN110621377A (zh) 2017-04-04 2019-12-27 贝奥密美体合资有限公司 治疗和/或预防与放射和/或化疗暴露有关的副作用的方法、组合物以及试剂盒
IL269915B (en) 2017-04-13 2022-09-01 Galera Labs Llc Cancer immunotherapy combined with a macrocyclic ring pentase complex
CN111417400B (zh) 2017-09-29 2022-12-02 杜克大学 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法
CN107936030A (zh) * 2017-11-21 2018-04-20 西北民族大学 水溶性含溴铜卟啉及其溴取代衍生物、其合成方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284647A (en) 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5109016A (en) 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
KR0145953B1 (ko) 1991-07-19 1998-08-17 제임스 클리프튼 보올딩 슈퍼옥사이드의 불균화촉매로서 효과적인 질소를 포함하는 마크로사이클 릭리간드의 망간착물
US5296466A (en) 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
CN1222286C (zh) 1994-05-13 2005-10-12 孟山都公司 过亚硝酸盐分解催化剂的应用方法及其药物组合物
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
AU3758695A (en) 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
US6002026A (en) 1996-07-26 1999-12-14 The Trustees Of Princeton University Catalytic oxygenation of hydrocarbons by metalloporphyrin and metallosalen complexes
WO1998033503A1 (en) * 1997-02-05 1998-08-06 Board Of Regents, The University Of Texas System Porphyrin compounds as telomerase inhibitors
US6121278A (en) * 1997-09-03 2000-09-19 Guilford Pharmaceuticals, Inc. Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
US6448239B1 (en) * 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012105483A1 (ja) * 2011-01-31 2012-08-09 国立大学法人宇都宮大学 ポルフィリン型骨格を有する化合物の金属錯体の製造方法
JP2015020986A (ja) * 2013-07-22 2015-02-02 学校法人同志社 抗癌剤、金属錯体及び複素環化合物

Also Published As

Publication number Publication date
US6969707B2 (en) 2005-11-29
WO2000075144A8 (en) 2001-08-09
US6448239B1 (en) 2002-09-10
WO2000075144A9 (en) 2002-07-11
EP1185532A1 (en) 2002-03-13
AU5460300A (en) 2000-12-28
AU780118B2 (en) 2005-03-03
US20030055032A1 (en) 2003-03-20
WO2000075144A3 (en) 2001-06-28
US20060199792A1 (en) 2006-09-07
WO2000075144A2 (en) 2000-12-14
CA2373336A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
JP2003501432A (ja) ペルオキシ亜硝酸塩分解触媒およびその使用方法
US8334377B2 (en) Porphyrin catalysts and methods of use thereof
US8232267B2 (en) Porphyrin catalysts and methods of use thereof
EP1212323B1 (en) Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
EP0679155B1 (en) Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP1301515B1 (en) Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
EP0345171B1 (fr) Dérivés de métalloporphyrines, leur préparation, leur application en thérapeutique et leur utilisation pour la préparation de molécules hybrides
MXPA06011244A (es) Compuestos de porfirina sustituida por piridilo, y metodos de uso de los mismos.
KR20190112330A (ko) 치료용 덴드리머
US9365593B2 (en) Photolabile caged transition metal complexes and methods of using the same
JP2000508625A (ja) スーパーオキシドをジスムテートする触媒として有効な窒素含有大環状リガンドのマンガンまたは鉄錯体の生体分子結合体
JP2002506855A (ja) 細胞毒性金属キレート剤とその製法及びその使用方法
US20060241095A1 (en) Orally bioavailable low molecular weight metalloporphyrins as antioxidants
CZ277698A3 (cs) Komplexy železa makrocyklických ligandů obsahujících dusík, působící jako katalyzátory pro dismutaci superoxidu
US20070185072A1 (en) Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
CN112266396A (zh) 一种基于生物正交化学的整合型前药、制备方法及其医药用途
MXPA98007449A (en) Complexes with iron of macrocyclic ligands containing nitrogen, effective as catalysts to dismute superox

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20070807